Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Definium Therapeutics Reports $158.99 Million Net Loss and Significant Asset Growth in Latest Filing
Definium Therapeutics Reports Increased Losses and Advances in Clinical Programs for Q1 2026
Definium Therapeutics Reports $183.8M Net Loss and Advances Clinical Trials